Digital Health Global / Business Wire · May 2026
BIOS-backed spinout Kordata Dynamics launched an AI platform for precision clinical trials powered by BIOS NeuroTune; Emil Hewage said the vision is to compress trial timelines while preserving rigor.
Neural interfaces to understand and use nerve data in medicine.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
BIOS Health is a Cambridge-founded neural engineering / bioelectronic medicine company that builds AI-powered neural interfaces and Neural Digital Therapy products to read and write neural signals, derive neural biomarkers, and personalize treatments for chronic disease.
Primary product
BIOS NeuroTune and the broader BIOS Therapy Development Platform for neural biomarker discovery and personalized neuromodulation dosing
Founded
2015
Headquarters
Cambridge, Cambridgeshire, United Kingdom
Team size
11-50
Work style
Hybrid
Industry
Biotechnology Research
Sub-industry
Neural engineering / bioelectronic medicine
Offices
Cambridge, Cambridgeshire, United Kingdom (HQ / R&D headquarters)
8 Bateman Mews, Cambridge, CB2 1NN, United Kingdom
Montreal, Quebec, Canada (AI R&D Centre / MILA)
Bakersfield, California, United States (Commercial Precision Medicine Centre / West Coast hub)
Business model
B2B platform partnerships
co-development with clinics and pharma
research collaborations
enterprise software/platform licensing
Funding
Stage
growth
Total raised
$46.8M
Latest round
Growth round · Jan 2024
Jan 2024 · Kern Venture Group
Jun 2023 · Selvedge Venture / XTX Ventures
Nov 2022 · National Institutes of Health
Feb 2021 · National Institutes of Health (SPARC Program)
Non-equity assistance / grants
Sep 2019 · Cisco / MassChallenge UK / Innovate UK / Founder.org
Dec 2018 · Real Ventures / AME Cloud Ventures / Ariel Poler
People & investors
Leadership
CEO & Founder
Co-Founder & Senior Scientific Advisor
Board Chair
Work & culture
Mission-driven, collaborative, and research-heavy; public recruiting language emphasizes solving hard problems, being patient-centric, and maintaining a fun, friendly, diverse environment.
Work style
Hybrid
Compensation
No public salary bands found. Public compensation signals include competitive salary, share options for all employees, enhanced pension contributions, private health/dental coverage, EAP support, gym contributions, and home-working equipment.
Benefits
Competitive salary
Share options
Enhanced pension contributions
Private health insurance
Private dental insurance
Employee Assistance Programme (EAP)
Gym membership contributions
Home-working equipment
Product & market
Pricing
Custom enterprise / partnership pricing; no public price list found
Differentiators
- —Reads and writes neural signals in real time
- —Uses neural biomarkers to personalize dosing
- —NeuroTune can personalize neuromodulation settings in under 10 minutes
- —Claims 15x faster discovery than competing platforms
- —Modular platform spanning discovery, translation, validation, and commercialization
- —Works via long-term co-development partnerships
- —Focuses on both bioelectronic and molecular therapies
Technology
AI / machine learning
neural signal processing
React
TypeScript
Python
PostgreSQL
Terraform
Docker
CI/CD
cloud infrastructure
Customers
Academics and researchers
Neuromodulation companies
Pharma companies
Clinics
CROs
NIH SPARC / REVEAL collaborators
Competitors
Abbott
Medtronic
Galvani Bioelectronics
Neuralink
Combinostics
Scale & contact
Estimated revenue
$1M-$10M
Estimated monthly visits
2.5K
Traffic estimate as of Jul 2026
Latest news
Business Wire · Jan 2024
BIOS announced a West Coast hub in Bakersfield with Kern Venture Group, positioned as a clinical trials and R&D center for neural digital therapies and commercialization in the US.
Sifted · Jun 2023
Sifted reported BIOS raised a fresh round led by Selvedge Venture and XTX Ventures; the amount was described as more than $20m.
BIOS Health · Nov 2022
Official announcement that NIH-funded REVEAL would deploy BIOS technology across eight clinics for a $21m, three-year human vagus nerve study.
BIOS Health · Feb 2021
Official page stating BIOS received an NIH SPARC award to accelerate neural treatment design, with a first-year award of $0.9m and potential total funding of about $1.4m.
Jobs and careers at BIOS Health
0 jobs at BIOS Health
No open positions
Check back later for new openings